Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 4
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Validity of the CR-POSSUM model in surgery for colorectal cancer in Spain (CCR-CARESS Study) and comparison with other models to predict operative mortality

  • Baré i Mañas, Marisa|||0000-0001-8085-2833
  • Alcántara Moral, Manuel Jesús
  • Gil, Maria José
  • Collera-Ormazabal, Pablo|||0000-0002-0517-5382
  • Pont, Marina
  • Escobar, Antonio
  • Sarasqueta, Cristina
  • Redondo, Maximino
  • Briones, Eduardo
  • Dujovne, Paula
  • Quintana López, José María|||0000-0003-2170-7876
Background: To validate and recalibrate the CR- POSSUM model and compared its discriminatory capacity with other European models such as POSSUM, P-POSSUM, AFC or IRCS to predict operative mortality in surgery for colorectal cancer. Methods: Prospective multicenter cohort study from 22 hospitals in Spain. We included patients undergoing planned or urgent surgery for primary invasive colorectal cancers between June 2010 and December 2012 (N= 2749). Clinical data were gathered through medical chart review. We validated and recalibrated the predictive models using logistic regression techniques. To calculate the discriminatory power of each model, we estimated the areas under the curve - AUC (95% CI). We also assessed the calibration of the models by applying the Hosmer-Lemeshow test. Results: In-hospital mortality was 1.5% and 30-day mortality, 1.7%. In the validation process, the discriminatory power of the CR-POSSUM for predicting in-hospital mortality was 73.6%. However, in the recalibration process, the AUCs improved slightly: the CR-POSSUM reached 75.5% (95% CI: 67.3-83.7). The discriminatory power of the CR-POSSUM for predicting 30-day mortality was 74.2% (95% CI: 67.1-81.2) after recalibration; among the other models the POSSUM had the greatest discriminatory power, with an AUC of 77.0% (95% CI: 68.9-85.2). The Hosmer-Lemeshow test showed good fit for all the recalibrated models. Conclusion: The CR-POSSUM and the other models showed moderate capacity to discriminate the risk of operative mortality in our context, where the actual operative mortality is low. Nevertheless the IRCS might better predict in-hospital mortality, with fewer variables, while the CR-POSSUM could be slightly better for predicting 30-day mortality.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

COPD is a clear risk factor for increased use of resources and adverse outcomes in patients undergoing intervention for colorectal cancer, a nationwide study in Spain

  • Baré i Mañas, Marisa|||0000-0001-8085-2833
  • Montón, Concepción
  • Mora, Laura
  • Redondo, Maximino
  • Pont, Marina
  • Escobar, Antonio
  • Sarasqueta, Cristina
  • Fernández de Larrea, Nerea
  • Briones, Eduardo
  • Quintana López, José María|||0000-0003-2170-7876
We hypothesized that patients undergoing surgery for colorectal cancer (CRC) with COPD as a comorbidity would consume more resources and have worse in-hospital outcomes than similar patients without COPD. Therefore, we compared different aspects of the care process and short-term outcomes in patients undergoing surgery for CRC, with and without COPD. This was a prospective study and it included patients from 22 hospitals located in Spain - 472 patients with COPD and 2,276 patients without COPD undergoing surgery for CRC. Clinical variables, postintervention intensive care unit (ICU) admission, use of invasive mechanical ventilation, and postintervention antibiotic treatment or blood transfusion were compared between the two groups. The reintervention rate, presence and type of complications, length of stay, and in-hospital mortality were also estimated. Hazard ratio (HR) for hospital mortality was estimated by Cox regression models. COPD was associated with higher rates of in-hospital complications, ICU admission, antibiotic treatment, reinterventions, and mortality. Moreover, after adjusting for other factors, COPD remained clearly associated with higher and earlier in-hospital mortality. To reduce in-hospital morbidity and mortality in patients undergoing surgery for CRC and with COPD as a comorbidity, several aspects of perioperative management should be optimized and attention should be given to the usual comorbidities in these patients.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Factors associated with readmissions in women participating in screening programs and treated for breast cancer, A retrospective cohort study

  • Miret, Carme|||0000-0001-6154-3998
  • Domingo, Laia|||0000-0003-4420-0891
  • Louro, Javier|||0000-0002-2985-3301
  • Barata, Teresa
  • Baré i Mañas, Marisa|||0000-0001-8085-2833
  • Ferrer, Joana
  • Carmona-Garcia, M. Carmen|||0000-0002-4011-9474
  • Castells, Xavier|||0000-0002-2528-0382
  • Sala, Maria|||0000-0002-9955-8746
Background: We aimed to identify the risk factors associated with early, late and long-term readmissions in women diagnosed with breast cancer participating in screening programs. Methods: We performed a multicenter cohort study of 1055 women aged 50-69 years participating in Spanish screening programs, diagnosed with breast cancer between 2000 and 2009, and followed up to 2014. Readmission was defined as a hospital admission related to the disease and/or treatment complications, and was classified as early (< 30 days), late (30 days-1 year), or long-term readmission (.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Exploring the Role of Breast Density on Cancer Prognosis among Women Attending Population-Based Screening Programmes

  • Domingo, Laia|||0000-0003-4420-0891
  • Sala, Maria|||0000-0002-9955-8746
  • Louro, Javier|||0000-0002-2985-3301
  • Baré i Mañas, Marisa|||0000-0001-8085-2833
  • Barata, Teresa
  • Ferrer, Joana
  • Carmona-Garcia, M. Carmen|||0000-0002-4011-9474
  • Comas Serrano, Mercè|||0000-0003-1926-2740
  • Castells, Xavier|||0000-0002-2528-0382
Background. Our aim was to assess the role of breast density on breast cancer mortality and recurrences, considering patient and tumour characteristics and the treatments received among women attending population-based screening programmes. Methods. We conducted a retrospective cohort study among women aged 50-69 years attending population-based screening programmes, diagnosed with invasive breast cancer between 2000 and 2009, and followed up to 2014. Breast density was categorised as low density (≤25% dense tissue), intermediate density (25-50%), and high density (≥50%). Cox proportional hazards regression models were fitted to estimate the adjusted hazard ratios (aHR) and 95% confidence intervals (95% CI) for death and recurrences, adjusting by patient characteristics, mode of detection (screen-detected vs. interval cancer), and tumour features. Results. The percentage of deaths and recurrences was higher among women with intermediate- and high-density breasts than among women with low-density breasts (p=0.011 for death; p=0.037 for recurrences). Adjusted Cox proportional hazards regression models revealed that women with intermediate- and high-density breasts had a higher risk of death than women with low-density breasts, being statistically significant for intermediate densities (aHR = 2.19 [95% CI: 1.16-4.13], aHR = 1.44 [95% CI: 0.67-3.1], respectively). No association was found between breast density and recurrences. Conclusions. Breast density was associated with a higher risk of death, but not of recurrences, among women participating in breast cancer screening. These findings reinforce the need to improve screening sensitivity among women with dense breasts and to routinely assess breast density, not only for its role as a risk factor for breast cancer but also for its potential influence on cancer prognosis.